Edition:
United Kingdom

Trillium Therapeutics Inc (TRIL.OQ)

TRIL.OQ on NASDAQ Stock Exchange Capital Market

2.21USD
11 Dec 2018
Change (% chg)

-- (--)
Prev Close
$2.21
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
18,557
52-wk High
$11.45
52-wk Low
$2.01

Chart for

About

Trillium Therapeutics Inc is a Canada-based clinical stage immuno-oncology company developing therapies for the treatment of cancer. The Company leads program, TTI-621, which is a SIRPaFc fusion protein that consists of the CD47-binding domain of human SIRPa linked to the Fc region of a human immunoglobulin (IgG1). It is... (more)

Overall

Beta: 1.58
Market Cap(Mil.): $70.92
Shares Outstanding(Mil.): 10.79
Dividend: --
Yield (%): --

Financials

  TRIL.OQ Industry Sector
P/E (TTM): -- 92.25 33.63
EPS (TTM): -5.03 -- --
ROI: -52.37 0.29 15.02
ROE: -126.37 0.94 16.60

Earnings vs. Estimates